Early research (Phase 1)Study completedNCT00002687What this trial is testingInterleukin-2 in Treating Patients With Mycosis FungoidesWho this might be right forLymphoma University of Washington 30
Early research (Phase 1)Study completedNCT00002759What this trial is testingIrinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaWho this might be right forDrug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT04676087What this trial is testingMogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis FungoidesWho this might be right forMycosis FungoidesPrimary Cutaneous T-Cell Non-Hodgkin LymphomaSezary Syndrome Emory University 5
Testing effectiveness (Phase 2)Study completedNCT00002479What this trial is testingTretinoin in Treating Patients With Mycosis Fungoides or Sezary SyndromeWho this might be right forLymphoma Northwestern University
Early research (Phase 1)Study completedNCT00890747What this trial is testingSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)UnknownNCT00030589What this trial is testingChemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell LymphomaWho this might be right forLymphoma Millennix
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Not applicableEnded earlyNCT00900068What this trial is testingBlood Samples From Patients on a Clinical Trial to CINV During HSCTWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 9
Early research (Phase 1)WithdrawnNCT02548468What this trial is testingReduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell LymphomaWho this might be right forCutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides and Sezary SyndromeStage IIB Mycosis Fungoides and Sezary Syndrome+4 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Study completedNCT00255749What this trial is testingEpoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Jonsson Comprehensive Cancer Center 89
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Not applicableStudy completedNCT00003196What this trial is testingLow-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more Fred Hutchinson Cancer Center 63
Large-scale testing (Phase 3)Study completedNCT00003883What this trial is testingItraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 578
Not applicableStudy completedNCT00897923What this trial is testingImaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's LymphomaWho this might be right forLymphomaSmall Intestine Cancer Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00074087What this trial is testingLiposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis FungoidesWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 49
Testing effectiveness (Phase 2)Study completedNCT01093586What this trial is testingDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more Case Comprehensive Cancer Center 14
Not applicableLooking for participantsNCT01137825What this trial is testingRegistry of Older Patients With CancerWho this might be right forChronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more UNC Lineberger Comprehensive Cancer Center 3,000
Early research (Phase 1)Study completedNCT00659568What this trial is testingMetformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaWho this might be right forBreast CancerEndometrial CancerKidney Cancer+3 more London Health Sciences Centre 28
Early research (Phase 1)WithdrawnNCT03617224What this trial is testingPembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary SyndromeWho this might be right forCutaneous T-Cell Lymphomas University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT00438958What this trial is testingSibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more The Canadian Blood and Marrow Transplant Group 230